Nilotinib (Tasigna)

( DrugBank: Nilotinib / KEGG DRUG: Nilotinib )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01166139 (ClinicalTrials.gov)	July 2010	1/7/2010	Nilotinib in the Treatment of Systemic Sclerosis	Phase IIA Study of the Safety and Tolerability of the Use of Nilotinibin the Treatment of Systemic S ...	Systemic Sclerosis	Drug: Nilotinib (Tasigna)	Hospital for Special Surgery, New York	Rudolph Rupert Scleroderma Program;Novartis Pharmaceuticals	Completed	18 Years	N/A	All	10	Phase 2	United States

First Previous1Next Last